Solar UV radiation is the main risk factor for cutaneous squamous cell carcinoma (SCC), but infections with skin human papillomavirus (HPV) types have also been linked to the development of SCC. Little is known about the natural history of these infections and whether the seroprevalence of skin HPV types is affected by ambient or individual levels of sun exposure. This study investigated this by analysing sera for antibodies to 26 skin HPV types from five phylogenetic genera obtained from 807 healthy individuals from the Netherlands, Italy and Australia, countries with strong differences in sunlight intensity. Overall HPV seroprevalence was similar across the three countries (50-57 % for b-HPV types, 40-48 % for c-HPV types), and the most frequent b-HPV and c-HPV types were the same in all countries. The highest seroprevalences for 24 of the 26 skin HPV types were observed in Italy (14 types) and Australia (ten types). Seroprevalence among men was generally higher than among women, and the male sex was significantly associated with both b-HPV [odds ratio (OR) 2.81, 95 % confidence interval (CI) 1.64-4.82] and c-HPV (OR 2.42, 95 % CI 1.40-4.18) antibodies in Australia. The only measure of sun sensitivity or UV exposure significantly associated with skin HPV seroprevalence was found for weekend sun exposure in Australia and b-HPV antibodies. It was concluded that type spectra and HPV seroprevalence are similar in countries with different sunlight intensity, and that levels of UV exposure do not play a strong role in the development of skin HPV antibodies in this study population.
INTRODUCTION
Papillomaviruses (PVs) constitute a family of small, nonenveloped, double-stranded DNA viruses. One hundred and eighteen different virus types have been fully characterized, of which almost 100 infect humans (de Villiers et al., 2004) , but more recent analyses have revealed a large number of putatively novel types (Forslund, 2007) .
Based on the open reading frame encoding the major capsid protein, L1, PVs are phylogenetically classified into genera (.40 % nucleotide sequence diversity), species (30-40 % nucleotide sequence diversity) and types (10-30 % nucleotide sequence diversity). There are five genera encompassing human PVs (HPVs): Alpha-, Beta-, Gamma-, Mu-and Nupapillomavirus.
HPVs can infect cutaneous or mucosal epithelia. The socalled high-risk types from the alphapapillomaviruses (aHPVs), most importantly HPV-16, infect genital and oral mucosa and are well-established causes of cervical, other anogenital and some oropharyngeal cancers, whilst the low-risk types (mainly HPV-6 and -11) are associated with benign genital and oral warts (zur Hausen, 2002) . Cutaneous HPV types from the a-HPVs (e.g. HPV-2 and -3), gammapapillomaviruses (c-HPVs; e.g. HPV-4), mupapillomaviruses (m-HPVs; e.g. HPV-1) and nupapillomaviruses (n-HPVs; HPV-41) cause common and flat skin warts (Jablonska et al., 1997) .
The first evidence that skin HPV types from the b-HPVs may play a role in the development of cutaneous squamous cell carcinoma (SCC) came from observations of patients with the rare disease epidermodysplasia verruciformis, who frequently develop cutaneous SCC (Orth, 2005; Pfister, 2003) . These patients suffer from a genetic defect that renders them susceptible to high-viral-load infection with b-HPVs (Dell' Oste et al., 2008) , and in more than 90 %, HPV types from the genus Betapapillomavirus (e.g. have been detected in the tumour.
Further evidence has been derived from iatrogenically immunosuppressed organ-transplant recipients, among whom there is a markedly increased risk for cutaneous SCC compared with the immunocompetent population and a reversal of the usual basal-cell carcinoma to SCC ratio of 4 : 1 (Oberyszyn, 2008) . In organ-transplant recipients, b-HPV DNA is frequently detected in skin cancer and its precursor lesions, mainly actinic keratoses, suggesting a role for b-HPVs in skin cancer development (Berkhout et al., 2000; de Jong-Tieben et al., 1995; Harwood et al., 2000) .
The main cause of cutaneous SCC is exposure to UV radiation, but evidence is accumulating to suggest that bHPVs may also play an adjunct role in immunocompetent populations. Several recent epidemiological studies support an association between the presence of b-HPV DNA and SCC Struijk et al., 2003 Struijk et al., , 2006 . Antibodies against the major capsid protein L1 are generally considered to be markers of past or present HPV exposure, and increased seroreactivity to skin HPV types has been reported to be associated with cutaneous SCC (Andersson et al., 2008; , reviewed by Casabonne et al., 2007 .
Despite the evidence that b-HPVs play a potentially causal role in skin cancer, little is known about the natural history of cutaneous HPV infections in adult immunocompetent populations who are unaffected by skin cancer. Mode and time of transmission, the immune response to infection and its duration, and factors associated with cutaneous HPV infection, such as sunlight exposure, are largely unclear. The prevalence of skin HPV seropositivity and type distribution across different populations has been systematically described only for the German population and it is not known whether similar overall and type-specific prevalences are observed in other populations. Furthermore, there is little knowledge of the factors that might be associated with HPV infection, and the question of whether HPV causally contributes to the development of SCC cannot be answered without knowing whether its main risk factor, UV exposure, also has a direct effect on HPV.
Using multiplex serology, a recently developed method for high-throughput analysis of sera for antibodies to up to 100 different antigens simultaneously (Waterboer et al., 2005 , we report here a cross-sectional study among healthy controls from a multi-centre case-control study of cutaneous SCC conducted in three countries among immunocompetent populations living at different latitudes. We aimed to describe antibody responses to 26 skin HPV types and to explore possible factors associated with HPV infection, particularly solar UV exposure.
METHODS
Study participants. Recruitment of participants took place within a multi-centre case-control study performed in the Netherlands, Italy and Australia that investigated the relationship between HPV infection, UV radiation and skin cancer. The study was approved by the local medical ethics committees and patients gave their written informed consent. The analyses described in this manuscript were restricted to the skin-cancer-free controls for whom serology data were available.
The Dutch study participants were selected from a case-control study investigating risk factors for skin cancer (De Hertog et al., 2001; Struijk et al., 2003) . Briefly, 275 controls with no history of any type of skin cancer who were age-and sex-matched to a series of cases with cutaneous SCC were recruited at the ophthalmology outpatient clinic at the Leiden University Medical Center according to criteria that have been described previously (Struijk et al., 2006) . The 256 Italian control participants were selected from the dermatology, rheumatology and surgery outpatient clinics at the Istituto Dermopatico dell'Immacolata in Rome. Patients with skin tumours and skin diseases possibly related to HPV infection (e.g. psoriasis vulgaris or lupus erythematodes) were excluded from the analyses. Eligible controls suffered from arterial problems such as peripheral arteriopathy or carotid stenosis, varicose veins, lipomas and inguinal hernia. In Australia, a total of 276 eligible participants was enlisted, 191 from Brisbane and 85 from Townsville in North Queensland. In Brisbane, 133 controls were randomly selected from the electoral roll (a register with almost complete population coverage) and 58 from skin cancerfree patients attending primary practice skin cancer clinics for routine self-referred screening. Controls in Townsville were selected randomly from a series of 14 community groups. Participants who reported a diagnosis of any skin tumour within 2 years prior to recruitment were excluded. Among the control participants from Australia, 52 (19 %) reported having had a previous basal-cell carcinoma. Sensitivity analyses revealed that their inclusion made no substantial difference to the results of this study.
Data collection. Questionnaires and medical charts were used to gather the following information: sex and age; level of education; UVrelated factors such as ability to tan, sun reactivity, (Fitzpatrick) skin type, sun exposure on work days and weekend days, and number of painful sunburns before the age of 20 years; and other potential risk factors such as smoking and alcohol consumption.
On: Fri, 26 Jul 2019 18:46:14 Skin phototype was recategorized into 'olive', 'medium' and 'fair' depending on responses to the questions about tanning ability, sun reactivity and Fitzpatrick skin type as described previously (Bouwes Bavinck et al., 2007) . In the Netherlands, only Fitzpatrick skin type was assessed, and types III and IV were always categorized as olive skin phototypes. Therefore, medium and fair skin phototypes were under-represented in the Netherlands compared with Italy and Australia, because in these two countries some individuals with Fitzpatrick skin types III and IV were also recategorized into the medium or fair skin phototype groups.
The categorization of work day ('chronic') and weekend day sun exposure as well as alcohol consumption was performed as described previously (Bouwes Bavinck et al., 2007) . Education was categorized as low level (at most, high school), middle level (technical or business school) or high level (college or university). Hair colour at the age of 20 years was assessed as black, brown, dark blond, blond or red, and was categorized into three groups (black or brown, dark blond or blond, and red). Cigarette pack years were calculated from the number of cigarettes per day divided by 20, multiplied by the duration (years) of smoking. For the Dutch study population, data on education and alcohol consumption were not available.
Human sera. Human sera were stored at 220 uC until analysis. Frozen serum samples were shipped on dry ice to the analysis laboratory at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. All serum analyses were performed blind with respect to the case or control status of the respective study participants.
Multiplex serology. The analysis of serum samples for HPV antibodies has been described in detail elsewhere Waterboer et al., 2005) . Briefly, recombinant HPV major capsid (L1) proteins were bacterially expressed as double fusion proteins with N-terminal glutathione S-transferase (GST) and a C-terminal peptide (tag) consisting of the last 11 aa from the large T-antigen of simian virus 40 (Sehr et al., 2002) . Bacterial pellets were lysed with a high-pressure homogenizer, lysates were cleared from insoluble components by centrifugation and supernatants were stored with 50 % glycerol at 220 uC. Fusion proteins were characterized by Coomassie-stained SDS-PAGE, Western blot analyses using GST and tag-specific antibodies, and GST-capture ELISA (Sehr et al., 2001 ).
Serum samples from study participants were analysed for antibodies to the L1 proteins of the cutaneous types HPV-2 and -3 (a-PVs), (species 1 of b-PVs), , , HPV-92 (b4-PV species), , HPV-1 and -63 (m-PVs) and HPV-41 (n-PVs), as well as the mucosal types HPV-6 and -16 (a-PVs), as described previously Waterboer et al., 2005) . In addition, the VP1 proteins of the human polyomaviruses BK and JC were included as control antigens (Kjaerheim et al., 2007) . Briefly, GST-L1-tag fusion proteins from cleared lysates were affinity purified in situ by binding to glutathione-casein-coated fluorescent-labelled polystyrene beads. Each fusion protein was bound to a spectrally distinct bead set (SeroMAP Microspheres; Luminex). Fusion protein-loaded bead sets were mixed. Sera were pre-incubated at a 1 : 50 dilution in PBS containing 1 mg casein ml 21 and 2 mg lysate ml 21 from bacteria expressing GST-tag alone to block antibodies directed against residual bacterial proteins, and GST-tag, 0.5 % polyvinylalcohol, 0.8 % polyvinylpyrrolidone and 2.5 % SuperChemiBlock (Millipore) to suppress non-specific binding of antibodies to the beads themselves . Serum dilutions were incubated with the same volume of mixed bead sets, resulting in a final serum dilution of 1 : 100. Bound antibodies were detected with biotinylated goat antihuman IgG (H+L) secondary antibody and streptavidin-R-phycoerythrin. A Luminex 100 analyser was used to identify the internal colour of the individual beads and to quantify their reporter fluorescence [expressed as median fluorescence intensity (MFI) of at least 100 beads per set per serum]. A fusion protein consisting of GST and tag without intervening viral antigen was used for individual serum background determination.
Assay design and data processing. The glutathione-caseincoupled bead sets were loaded with their respective antigens in one batch. Correct antigen loading was verified by using 28 reference sera with known HPV antibody patterns from two earlier studies (Karagas et al., 2006; and two monoclonal antibodies against HPV-6 and -16. Study sera were analysed once on three consecutive assay days. Every day, binding of GST-L1-tag fusion proteins to glutathione-casein-coated beads was quantified by antitag monoclonal antibody. Anti-tag MFI values for the first day varied less than twofold (range 7773-14904 MFI) and the inter-antigen coefficient of variation (CV) was 17.2 %, indicating similar full-length L1 fusion protein density for the different HPV types. Antigenspecific ratios of anti-tag MFI for the second (mean±SD, 0.99±0.19) and third (0.99±0.11) day revealed stable antigen binding to the beads throughout the three assay days.
A quality control (QC) panel of 94 sera was included each day, resulting in three QC datasets to determine inter-day variation. Pearson correlation coefficients (R 2 ) of raw MFI values for the individual antigens ranged from 0.742 to 0.999 (median 0.976) for day 2 versus day 1, and from 0.796 to 0.999 (median 0.971) for day 3 versus day 1. The raw data from days 2 and 3 for each antigen were divided by the slopes of the regression lines of the QC data pairs of days 1 and 2 or days 1 and 3, respectively, to correct for inter-day variation.
The reference sera used for correct antigen loading were also pooled and included as standard on each plate; this was seropositive for all antigens except HPV-93. The inter-plate CV of the plate standard for the various antigens across all assay days ranged from 4.9 to 26.8 %, with a median of 13.7 %, indicating low plate-to-plate variation.
Autofluorescence of each bead set and background reactions resulting from binding of secondary reagents to the antigen-loaded beads were determined in one well per plate without human serum. After correction for inter-day variation, mean bead background values (range 4-30 MFI for HPV antigens and JC VP1, 60 MFI for BK VP1) were subtracted from raw MFI values, and antigen-specific reactivity was determined by subtraction of the MFI of GST-tag from the MFI of the specific antigen. Cut-off values to define seropositivity for all antigens were set to 200 MFI as described previously .
UV index. To explore differences in sun intensity (mainly dependent on geographical latitude), country-specific data on the erythemal UV index was obtained from the Tropospheric Emission Monitoring Internet Service (TEMIS) of the European Space Agency, which records daily UV index measurements (http://www.temis.nl/). The UV index is an estimation of UV levels on an open-ended linear scale, with higher values representing the risk level of skin damage due to UV exposure (1 U525 mW m
22
). The median UV indices for Brisbane (Australia, 27u 289 S), Rome (Italy, 41u539 N) and De Bilt, near Leiden, (The Netherlands, 52u 69 N) from 1 July 2002 to 30 June 2007 were calculated to estimate country-specific UV intensities. Individual UV index hours were calculated as five times the mean work day sun exposure in hours plus two times the mean weekend day sun exposure in hours, multiplied by the country-specific median UV index values. Values ranged between 0 and 343, and for the analysis of associations, UV index hours were categorized into tertiles of the overall distribution (category 1, ,67; category 2 , 67-129; category 3, ¢130 UV index hours).
Statistical analysis. As main HPV outcomes, we used overall positivity to any b-and c-HPV types. We also analysed for multiple seropositivity to b-HPV types (1-3 and 4+ positive) and c-HPV types (2+ positive) but found no dose-response relationships, so these data are not shown.
To achieve direct comparability, country-specific overall seroprevalences were directly age-standardized to the European standard population. All statistical analyses were performed with SAS version 9.1.3. A x 2 test (and Fisher's exact test in the case of small numbers) was used to compare categorical variables. For quantitative variables, Wilcoxon signed rank-sum and Kruskal-Wallis tests were used for comparisons of two and more than two groups, respectively. Odds ratios (ORs) and 95 % confidence intervals (CIs) were estimated using unconditional binary logistic regression. Trends were estimated incorporating the uncategorized quantitative variables in models. All tests were performed two-sided, and P values below 0.05 were considered statistically significant. Some group sizes varied due to missing values. The term 'significant' is used to describe statistical significance.
RESULTS

Description of study populations
The study included 275 participants from the Netherlands, 256 from Italy and 276 from Australia. The baseline characteristics of the participants were differently distri- 
Seroprevalence of HPV types
Age-standardized overall seroprevalences were similar for the three countries, and antibodies to b-HPV types were slightly more prevalent than to c-HPV types (b-HPV types: 50 % in the Netherlands, 57 % in Italy and 51 % in Australia, P50.617; c-HPV types: 44 % in the Netherlands, 40 % in Italy and 48 % in Australia, P50.529).
For 24 of the 26 skin HPV types, the highest seroprevalence was observed in Italy (14 types) or Australia (ten types) (Fig. 2) . HPV-8 was the most frequent b-HPV type in all countries, and the five most frequent b-HPV types were HPV-8, -15, -17, -38 and -49, irrespective of country. Similar observations were made for c-HPV types, with HPV-4 and -65 being the most or second most frequent type in all countries. Prevalence differences between the countries for HPV-4, -6, -15 and -50 were borderline significant (P50.034-0.048), except for HPV-1 (P,0.0001).
Among individuals who were seropositive for at least one b-HPV type, the proportion of persons with antibodies to more than one b-HPV type was 57 % in the Netherlands, 68 % in Italy and 70 % in Australia (P50.032), and the mean number of seropositive b-HPV types was 3.6 in the Netherlands, 4.3 in Italy and 4.6 in Australia. In contrast, among individuals who were seropositive for at least one c-HPV type, about 50 % of participants from all countries (52 % in the Netherlands, 51 % in Italy and 46 % in Australia) reacted with more than one c-HPV type (P50.569), and the mean number of seropositive c-HPV types was very similar in the three countries (2.2 in the Netherlands, 2.2 in Italy and 2.1 in Australia).
Age and sex distribution of HPV antibodies
Men showed higher seroprevalences than women for both b-HPV (Australia 61.0 vs 35.8 %, Italy 71.7 vs 59.8 %, the Netherlands 52.1 vs 51.9 %) and c-HPV (Australia 53.3 vs 32.1 %, Italy 45.3 vs 42.3 %, the Netherlands 47.1 vs 46.1 %) types, but the difference was very small in the Netherlands (Tables 2 and 3 ).
The risk of being b-seropositive increased nearly three times in Australian men compared with women (Table 3) .
There was some indication of an increasing b-HPV seroprevalence with increasing age, especially in Italy, but the associations were not significant (P trend 50.063) ( Table  2 ). There was no such age trend for c-HPV seroprevalence (Table 3) .
Associations between alcohol and smoking and seropositivity
Smoking increased the risk for HPV seropositivity in Italy, with significant results for both b-and c-HPV types (Tables 2 and 3) , and high alcohol consumption was significantly associated with c-HPV seropositivity in Australia (Table 3 ), but none of these associations was consistent across the three countries.
Associations between sun sensitivity and b-and c-HPV antibodies
In analyses by country, sun exposure measures were not associated with b-or c-HPV seropositivity with one exception: in Australia, higher levels of sun exposure on weekend days increased the risk of b-HPV seropositivity (OR51.85, 95 % CI 1.02-3.34). Red hair appeared to consistently increase the risk for b-HPV seropositivity and also (less strongly) for c-HPV seropositivity across all three countries, but these associations were not significant.
It is possible that the relative uniformity of skin types and sun exposure within countries obscured the ability to find an association between sun exposure behaviour and HPV seroprevalence. We therefore explored differences between countries to help elucidate this issue. Sun intensity depends mainly on geographical latitude and can be described by the UV index. We calculated the median UV index values from publicly available databases as 2.85 for the Netherlands, 4.65 for Italy and 8.91 for Australia. Thus, 1 h of sun exposure in Italy is about twice as intense as in the Netherlands and about half as intense as in Australia.
Individual behaviour plays a role in sun exposure, and we observed substantial differences in sun exposure behaviour between the three countries. Mean daily hours spent outside on work days and weekend days were 3.6 and 4.3 in the Netherlands, 3.4 and 3.7 in Italy and 2.1 and 3.2 in Australia, respectively. This was significantly less in Australia than in either of the two other countries for both work days and weekend days (all P values ,0.001). There was also a significant difference between the Netherlands and Italy with regard to weekend day sun exposure (P,0.001), but not for work days (P50.16). We combined
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the measure of country-specific UV intensity with selfreported individual sun exposure behaviour to create the measure 'UV index hours' (see Methods). Whilst 43.4 % of the men fell into the highest category (¢130 UV index hours), 41.3 % of the women fell into the lowest category (,67 UV index hours). However, there was no association between this variable and either b-or c-HPV seropositivity (Table 4) . Thus, differences in ambient UV intensity or sun exposure behaviour appear to be unlikely to explain observed country-specific differences in seropositivity.
DISCUSSION
Little is known about the natural history of infections with skin HPV types. To our knowledge, this study is the first to shed light on the seroprevalence of a broad variety of skin HPV types in immunocompetent populations of three countries living at different latitudes and thus sunlight intensities. Increased prevalences of HPV DNA and antibodies in cutaneous SCC cases compared with healthy controls have been reported a number of times (reviewed by Akgul et al., 2006; Casabonne et al., 2007) , but the question of whether this reflects a causal contribution of HPV cannot be answered without knowing whether the main risk factor for SCC, UV exposure, also has a direct effect on HPV. Therefore, we concentrated our analyses on markers for sun sensitivity and UV exposure.
In this study, we analysed more than 800 sera for antibodies to the capsid proteins of 26 skin HPV types. These antibodies are thought to reflect (i) past or present exposure to or infection with HPV (Dillner, 1999) , (ii) the viral capsid antigen load presented to the immune system and (iii) the immune response capabilities of the host. Proliferation of keratinocytes (e.g. in skin diseases such as psoriasis or during regeneration of the skin after severe burns) may be a fourth factor triggering a serological response (Favre et al., 1998; Termorshuizen et al., 2004) . Acquisition of skin HPV types probably occurs in early childhood (Antonsson et al., 2003; Weissenborn et al., 2009) . However, in a population-based German crosssectional study, we showed that seroprevalence to b-and c-HPV types is low in children, increases continuously with age and reaches its first peak at about 40 years in women and 50 years in men . These delayed but long-lasting antibody responses are thought to be a sign of decreasing capabilities of the cellular immunity to control the infection.
Despite differences in control selection (both the Dutch and the Italian studies recruited hospital controls, whilst the Australian study was population-based), the overall seroprevalence to both b-and c-HPV types was similar across countries, and the type-specific antibody patterns were almost identical. These results correspond exactly to our findings for the 'older adults' (.34 years) from the German HPV seroprevalence study , with the most frequent b-HPV type being HPV-8 (followed by , and HPV-4 and -65 the two most prevalent c-HPV types. The comparison of these results with other studies is hampered by different numbers of HPV types tested, and partly by methodological issues, but in two HPV and SCC case-control studies conducted in the USA (Karagas et al., 2006) and Sweden (Andersson et al., 2008) , each with eight b-HPV types tested, HPV-8, -38 and -15 were the most frequent among the controls. These data demonstrate that the distribution of (b-)HPV types may be very similar worldwide, at least in populations of largely European descent.
As in the German study , we identified an age plateau in seroprevalence of approximately 50 years and above. Consequently, there was no significantly increasing risk with age in our study participants, the majority of whom were already over this age. Our finding of higher seroprevalences in men than in women for both b-and c-HPV types, although not significant, is consistent with previous reports Karagas et al., 2006; . The reasons for this are currently unknown. One possibility among others, such as hormonal differences and more body hair in men, is that this is due to the higher levels of sun exposure in men than in women, as shown in this study. However, we found no convincing evidence of an association between b-or c-HPV seroprevalence and measures of sun sensitivity or UV exposure. One of the strong advantages of this study was the heterogeneity of sun exposure introduced by including people from countries with markedly different UV intensity. Even so, this did not reveal any obvious association with sun exposure. Multiple infections with b-HPV types occurred less frequently in the Netherlands, but we found no association between UV index hours and multiple seropositivity, suggesting that factors other than sun exposure are responsible for this difference.
UV light is a ubiquitous exposure, which poses challenges for epidemiological inquiry (Karagas et al., 2007) . The analysis of UV exposure based on the reported number of hours spent outside has limitations, e.g. with taking holiday seasons into account. The Australian study participants reported substantially fewer hours of sun exposure than those from Italy or the Netherlands, which probably reflects the rising public awareness of the skin cancer risk due to sun exposure in Australia in the last approximately 20 years and validates the information about sun exposure. However, as in all retrospective studies, recall bias cannot be excluded. Thus, lifetime sun exposure might be underestimated in the Australian study population.
The observation that participants with red hair had higher seroprevalence than those with other hair colours, if true, may be unrelated to sun susceptibility. Rather, if hair follicles do form a viral reservoir as suspected (de Koning et al., 2007) , the properties of red hair (such as fewer but thicker hairs in comparison with blond or brunette persons; Santos Nogueira & Joekes, 2004) might render people with red hair more susceptible to infection. Associations of smoking or alcohol consumption, or a combination of these, with HPV-associated malignancies such as cutaneous SCC or oropharyngeal cancer have been described (De Hertog et al., 2001; Herrero et al., 2003) , but to our knowledge no literature is available on the influence of either of these on the prevalence of cutaneous HPV types.
One further strength of our study was the analysis of serum samples from three countries in one laboratory under defined conditions. Multiplex serology has been well validated (Andersson et al., 2008; Casabonne et al., 2007; Karagas et al., 2006; and is a state-of-the-art technique for highthroughput analysis of sera for antibodies to multiple antigens. This makes methodological issues very unlikely as an explanation for any of our observations, and the differences found for b-and c-HPV types (for example, regarding the mean number of seropositive types) underscore the specificity of our findings. Furthermore, assuming that the reactivity of low-affinity cross-reactive antibodies decreases faster with increasing serum dilution than that of specific antibodies with higher affinity, the linear relationship between serum reactivities and endpoint titres implies the absence of substantial antibody cross-reactivity.
This study provides evidence that similar cutaneous HPV antibody prevalences can be observed across several different populations, and highlights the frequency with which multiple infections occur. Carriage of these viruses on the skin appears to be almost ubiquitous, with only a fraction of people mounting a detectable antibody response. The factors driving this response are currently unknown.
The high prevalence of antibodies to cutaneous HPV suggests that, if HPV does play a role in the aetiology of skin cancer, it is acting synergistically with other risk factors such as genetic susceptibility and UV exposure. Our data do not support a strong role for UV exposure in the development of HPV antibodies, which suggests that previously reported relationships between HPV antibodies and SCC are independent of sun exposure. However, this does not negate the distinct possibility of interactions between exposure to UV radiation and HPV infection resulting in seroconversion. Further research is needed to understand the characteristics of viral infection that lead to seroconversion and the way in which HPV infection may contribute to the risk of skin cancer.
